La FDA ha approvato VP-102 per curare il molluscum contagiosum.

Published Date: 27 Jul 2023

The FDA has approved VP-102 for the treatment of molluscum contagiosum, a contagious skin condition that is primarily affecting children and is spread through direct skin-to-skin contact. The drug was resubmitted as a new drug application, and it was accepted this time.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot